Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Proa-active Monitoring by Measuring Vital Signs Using a Fitbit for a 3-month Period Before, During, and After Chemotherapy in Patients With Cancer

NCT06680778 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT06680778
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06680778 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Proa-active Monitoring by Measuring Vital Signs Using a Fitbit for a 3-month Period Before, During, and After Chemotherapy in Patients With Cancer
Lead sponsor
Erasmus Medical Center
Phase
Observational
Overall status
Recruiting
Start date
July 1, 2025
Completion date
December 31, 2025
Enrollment
175 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, emergencies